Kentaro Narita

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Multiple Myeloma

Clinical Practice

Positron Emission Tomography

Top Venues

Leukemia & lymphoma

British journal of haematology

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study. Blood advances 8 (8) (2024)
Kentaro Narita, Akinao Okamoto, Sachiko Iba, Rikako Tabata, Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Masami Takeuchi, Kengo Takeuchi, Akihiro Tomita, Matsue Kosei
Analysis of the clinical features and outcomes of relapsed intravascular large B-cell lymphoma: a single center study. Leukemia & lymphoma (2024)
Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study. Blood advances 8 (8) (2024)
Daisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Real-world applicability of the international metabolic prognostic index in DLBCL: a validation cohort study. Blood advances (2024)
Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood advances 8 (1) (2023)
Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood advances 8 (1) (2023)
Ami Fukumoto, Kentaro Narita, Daisuke Ikeda, Yuka Uesugi, Rikako Tabata, Daisuke Miura, Masami Takeuchi, Matsue Kosei
Safety and efficacy of venetoclax for acute myeloid leukaemia in real-world clinical practice. Japanese journal of clinical oncology (2023)
Daisuke Ikeda, Toshiki Terao, Mitsuaki Oura, Atsushi Uehara, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Youichi Machida, Matsue Kosei
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood advances 8 (1) (2023)
Toshiki Terao, Takafumi Tsushima, Daisuke Ikeda, Ami Fukumoto, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Limited efficacy of high-dose methotrexate to prevent the central nervous system relapse in patients with IVLBCL. Leukemia & lymphoma (2022)
Kentaro Narita, Tomo Suzuki, Kosei Matsue
PET/CT imaging of renal intravascular large B-cell lymphoma. Clinical and experimental nephrology 26 (11) (2022)
Toshiki Terao, Takafumi Tsushima, Daisuke Miura, Daisuke Ikeda, Ami Fukumoto, Ayumi Kuzume, Rikako Tabata, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature review. Leukemia & lymphoma 63 (5) (2022)
Daisuke Ikeda, Takafumi Tsushima, Ami Fukumoto, Ayumi Kuzume, Rikako Tabata, Toshiki Terao, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Koichi Honma, Matsue Kosei
Rapid liver atrophy and refractory ascites due to hepatoportal sclerosis in a patient after haploidentical stem cell transplantation. Leukemia & lymphoma 63 (6) (2022)
Manabu Fujisawa, Tran B Nguyen, Yoshiaki Abe, Yasuhito Suehara, Kota Fukumoto, Sakurako Suma, Kenichi Makishima, Chihiro Kaneko, Yen T M Nguyen, Kensuke Usuki, Kentaro Narita, Matsue Kosei, Naoya Nakamura, Shumpei Ishikawa, Fumihito Miura, Takashi Ito, Ayako Suzuki, Yutaka Suzuki, Seiya Mizuno, Satoru Takahashi, Shigeru Chiba, Mamiko Sakata-Yanagimoto
Clonal germinal center B cells function as a niche for T-cell lymphoma. Blood 140 (18) (2022)
Toshiki Terao, Takashi Naduka, Daisuke Ikeda, Ami Fukumoto, Yuya Kamura, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Depletion of CD38-positive regulatory T cells by anti-CD38 monoclonal antibodies induces a durable response to SARS-CoV-2 vaccination in patients with plasma cell dyscrasia. British journal of haematology 197 (4) (2022)
Akihiro Kitadate, Toshiki Terao, Kentaro Narita, Sho Ikeda, Yuto Takahashi, Takafumi Tsushima, Daisuke Miura, Masami Takeuchi, Naoto Takahashi, Matsue Kosei
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence. Cancer science 112 (9) (2021)
Ayumi Kuzume, Rikako Tabata, Toshiki Terao, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure. British journal of haematology 193 (4) (2021)
Toshiki Terao, Youichi Machida, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Matsue Kosei
Pre-treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron-emission tomography/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice. British journal of haematology 191 (2) (2020)
Toshiki Terao, Hiroya Ashimine, Naoko Tsuyama, Daisuke Ikeda, Ayumi Kuzume, Rikako Tabata, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Kengo Takeuchi, Matsue Kosei
Development of BCR-ABL1-positive ɤδ T-cell leukemia after treatment for thymoma type B1. Leukemia & lymphoma 62 (5) (2020)
Akihiro Kitadate, Kentaro Narita, Kouta Fukumoto, Toshiki Terao, Takafumi Tsushima, Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Masami Takeuchi, Youichi Machida, Matsue Kosei
Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphoma. Cancer medicine 9 (15) (2020)
Toshiki Terao, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Matsue Kosei
Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach. EJHaem 1 (1) (2020)
Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Yoshiaki Abe, Daisuke Miura, Masami Takeuchi, Kosei Matsue
Neurolymphomatosis of the sciatic and tibial nerves as an initial presentation of lung diffuse large B cell lymphoma detected by positron emission tomography/computed tomography. International journal of hematology 110 (4) (2019)